Item | Week 0 | Week 1 | Week 5 | Week 9 | Week 17 | ||
---|---|---|---|---|---|---|---|
| PRIME-MD | √ | |||||
| Basic characteristicsa | √ | |||||
Electrocardiogram | √ | √ | |||||
Informed consent | √ | ||||||
BDI-II | √ | √ | √ | √ | √ | ||
| PHQ-9 | √ | √ | √ | √ | √ | |
FIBSER | √ | √ | √ | √ | √ | ||
Blindness | √ | √ | √ | ||||
Treatment satisfaction | √ | √ | |||||
| Allocation | √ | |||||
Participant | K6 | √ | √ | √ | √ | ||
(Only those allocated to Kokoro-App) | (Only those allocated to Kokoro-App) | (Only those allocated to Kokoro-App) |